NewsRx

Search our medical news database

CytoDyn

Recent developments from CytoDyn detailed

Published in Healthcare Finance, Tax and Law Weekly, February 7th, 2007

Recent developments from CytoDyn detailed.

This trend article is an immediate alert from NewsRx to identify the most recent news developments at CytoDyn.

Report 1: Because of a medical emergency and other unforeseen circumstances, CytoDyn, Inc. (CYDY) was late filing a 10-QSB for the first time.

The policy of NASD is to require an issuer with a first late filing that has since become current to wait for the processing of a new Form 211 before that issuer is again quoted on the Bulletin Board. Previously, the company waited five months for the Form 211 to be processed by NASD and might have had to wait even longer if the company...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook